Mega Life launch Pynocare pigmentation

Mega Life Sciences, has introduced an innovating quality product Pynocare, to the local market.

"The only oral solution to successfully treat dark spots, pigmentation and uneven skin tones in Sri Lanka, this product has been successfully marketed in the Philippines, Singapore, Malaysia, Thailand and Cambodia" said Country Manager, Mega Life Sciences, Sri Lanka, Praveen Viswakumaran, at the launch .

This launch was attended by celebrities and professionals in the beauty industry, including hair dresser and beautician, Ramani Fernando and Yolande Aluvihare Holms who has taken local fashion to the international markets, Sri Lankan Airlines Dr, Anoma Jayasinghe and others.

"Dark spots, pigmentation and uneven skin tones are common afflictions suffered by women in their thirties and above.

If left untreated, it can even cause severe damage to the skin. Brown skinned women such as Asians and Latinos are more likely to be afflicted than their fair-skinned European cousins, leaving them with brown and grey-brown

patches on their skin", Dermatologist, Dr Nayana Perera, said.

Ruchira Welipitiya, Brand Manager, Pynocare, said that unlike freckles which are genetic, pigmentation is entirely acquired and caused by environmental factors, thus, it is treatable.

"Available treatments however focus on the external - chemical therapies like topical depigmenting agents (creams and lotions that block melanin production) and chemical peels, such as microdermabrasion and laser treatment, which cause strong side effects. Pynocare combats pigmentation in an easy, safe and effective manner and is an oral solution that treats pigmentation internally, at the root level".

The pine bark and sea weed extracts found in each soft gel capsule of Pynocare form a cocktail of powerful antioxidants with strong anti-inflammatory properties. Pynocare has been evaluated by the Spin Control Institute, France (a world class research laboratory) and is clinically proven to be an effective treatment leading to significant results.

A double-blinded crossover control study performed at HUKM (Hospital University Kebangsaan Malaysia) proved the same. Established in 1983, Mega Life Sciences is a leading pharmaceutical company with a presence in more than 30 countries.

Mega Lifesciences is committed to providing quality products and services to its customers through constant improvement and innovation.

HDH